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Full left ventricular coverage 
is essential for the accurate 
quantification of the area-at-risk by 
T1 and T2 mapping
Heerajnarain Bulluck  1,2,5, Jennifer A. Bryant5, Mei Xing Lim5,6, Xiao Wei Tan5, Manish 
Ramlall1,2,3, Rohin Francis1,2,4, Tushar Kotecha4, Hector A. Cabrera-Fuentes  5,6,7,8,  
Daniel S. Knight4, Marianna Fontana4, James C. Moon2,3 & Derek J. Hausenloy1,2,3,5,6,9
T2-weighted cardiovascular magnetic resonance (CMR) using a 3-slice approach has been shown to 
accurately quantify the edema-based area-at-risk (AAR) in ST-segment elevation myocardial infarction 
(STEMI). We aimed to compare the performance of a 3-slice approach to full left ventricular (LV) 
coverage for the AAR by T1 and T2 mapping and MI size. Forty-eight STEMI patients were prospectively 
recruited and underwent a CMR at 4 ± 2 days. There was no difference between the AARfull LV and 
AAR3-slices by T1 (P = 0.054) and T2-mapping (P = 0.092), with good correlations but small biases and 
wide limits of agreements (T1-mapping: N = 30, R2 = 0.85, bias = 1.7 ± 9.4% LV; T2-mapping: N = 48, 
R2 = 0.75, bias = 1.7 ± 12.9% LV). There was also no significant difference between MI size3-slices and 
MI sizefull LV (P = 0.93) with an excellent correlation between the two (R2 0.92) but a small bias of 0.5% 
and a wide limit of agreement of ±7.7%. Although MSI was similar between the 2 approaches, MSI3-
slices performed poorly when MSI was <0.50. Furthermore, using AAR3-slices and MI sizefull LV resulted in 
‘negative’ MSI in 7/48 patients. Full LV coverage T1 and T2 mapping are more accurate than a 3-slice 
approach for delineating the AAR, especially in those with MSI < 0.50 and we would advocate full LV 
coverage in future studies.
Myocardial salvage index (MSI) is considered a more accurate measure to assess the cardioprotective efficacy of 
novel therapies aiming to reduce myocardial infarct (MI) size in reperfused ST-segment elevation myocardial 
infarction (STEMI) patients1–3 and it has recently been shown to reduce sample size compared to MI size3. To 
assess MSI, knowledge of both the MI size and the area-at-risk (AAR) are required and can be calculated using 
the formula MSI = 1 − (MI/AAR). Cardiovascular magnetic resonance (CMR) is considered the gold standard 
imaging modality for quantifying MI size4, and it can also provide information on the edema-based AAR5–7. 
T2-weighted short tau inversion recovery (STIR) imaging in the first week following primary percutaneous coro-
nary intervention (PPCI) has been used to delineate the AAR in reperfused STEMI patients, although its robust-
ness has recently been questioned8. T2-mapping9, 10 has emerged as a more robust technique for the AAR and 
native T1 mapping has also been shown to perform well against T2 mapping in a canine model of MI11, and in 
clinical patients at 3.0 T5.
The accurate quantification of the AAR conventionally requires full left ventricular (LV) coverage. Recently, a 
3-slice approach has been proposed for T2-weighted STIR imaging, with the obvious benefit of shorter scan and 
analysis time12. The main aim of this study was to assess whether the 3-slice approach will also perform as well 
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as full LV coverage, using T1 and T2 mapping to delineate the AAR. Secondly, we aimed to assess the impact of a 
3-slice approach for the AAR and MI size on MSI.
Results
Baseline clinical characteristics of the 48 patients are listed in Table 1. The mean age was 59 ± 13 years and 88% 
(42/48) male gender. The median onset-to-balloon time was 182 (128–328) minutes. CMR was performed at 4 ± 2 
days post PPCI. The mean MI size (using full LV coverage) was 27.4 ± 14.6% LV and late MVO occurred in 63% 
(30/48) of patients. The average number of T1 and T2 maps for full LV analysis was 8 ± 1 per patient.
T1 mapping versus T2 mapping, n = 30. In the 30 patients with full LV coverage for T1 and T2 maps, 
The AARfull LV was not significantly different between the 2 mapping techniques (42.6 ± 12.0% LV versus 
42.2 ± 11.9% LV, P = 0.44) with an excellent correlation and agreement on Bland-Altman analysis (R2 0.94, bias: 
0.4%, limits of agreement ±5.9%).
3-slice versus full LV AAR by T1 mapping, n = 30. There was no difference between the AARfull LV and 
AAR3-slices by T1 mapping [n = 30, 43 (34–51)% LV versus 40 (32–48)% LV, P = 0.054] and there was a good cor-
relation between the two (R2 0.85). However, there was a small bias of 1.7% LV and the limits of agreement were 
quite wide at ±9.4% LV.
3-slice versus full LV AAR by T2 mapping, n = 48. Likewise, for T2 mapping, there was no difference 
between the AARfull LV and AAR3-slices [n = 48, 41 (34–52)% LV versus 40 (32–51)% LV, P = 0.092] and there was a 
good correlation between the two (R2 0.75) (Fig. 1a). However, there was a small bias of 1.7% LV and the limits of 
agreement were quite wide at ±12.9% LV (Fig. 1b).
Full LV coverage MI size versus 3-slice MI size, n = 48. There was no significant difference between MI 
size3-slices and MI sizefull LV (P = 0.93) with a very good correlation between the two (R2 0.92) as shown in Fig. 2a. 
Bland-Altman analysis showed a small bias of 0.5% but there was a wide limit of agreement of ±7.7% (Fig. 2b).
Details Patients with full LV T2 maps Patients with full LV T1 maps
Number of patients 48 30
Male 40 (83%) 23 (77%)
Age 58 ± 13 55 ± 12
Diabetes Mellitus 9 (19%) 7 (23%)
Hypertension 15 (31%) 8 (27%)
Smoking 15 (31%) 11 (37%)
Dyslipidemia 15 (31%) 8 (27%)
Chest pain onset to PPCI time (minutes) 182 (128–328) 213 (131–385)
Infarct artery (%)
 LAD 28 (58%) 19 (63%)
 RCA 18 (38%) 9 (30%)
 Cx 2 (4%) 2 (7%)
Pre-PPCI TIMI flow (%)
 0 38 (80%) 21 (70%)
 1 1 (2%) 1 (3%)
 2 4 (8%) 3 (10%)
 3 5 (10%) 5 (17%)
Post-PPCI TIMI flow (%)
 0 1 (2%) 1 (3%)
 1 0 (0%) 0 (0%)
 2 10 (21%) 2 (7%)
 3 37 (77%) 27 (90%)
Timing of CMR/days 4 ± 2 3 ± 1
CMR findings
 LVEF/% 49 ± 8 52 ± 8
 LV Mass/g 113 ± 35 121 ± 27
 MI size/% LV 27.4 ± 14.6 25.6 ± 14.1
 AAR by T2/% LV 42.7 ± 11.9 42.2 ± 11.9
Table 1. Baseline clinical characteristics of STEMI patients. LAD: left anterior descending artery; RCA: right 
coronary artery; Cx: circumflex artery; TIMI: thrombolysis in myocardial infarction.
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MSI: 3-slice (whole LV coverage for MI size and 3 slices for AAR) versus full LV coverage. MSI 
was calculated using the formula MSI = 1 − (MI size/AAR), where MI size was quantified using full LV short axis 
coverage and AAR was quantified by using full LV coverage or 3 slices by T2 mapping and T1 mapping.
For T2 mapping (n = 48), the MSI was 0.35 (0.18–0.55) for T2 AARfull LV and 0.34 (0.14–0.54) for T2 AAR3-slices, 
P = 0.050 (Fig. 3). Although similar, the MSI3-slices performed poorly when the MSI was <0.50 compared to ≥0.50 
(R2 0.45 versus R2 0.91, P < 0.001), Fig. 4. Bland-Altman analysis showed a bias of 0.06 but a wide limit of agree-
ment of ±0.33. Furthermore, the 3-slice strategy underestimated the AAR in 7 out of 48 patients and resulted 
in a negative MSI (Figs 3 and 4). When these 7 patients were excluded, the R2 of the remaining 41 patients for 
MSI3-slices versus MSIfull LV was 0.90, with a bias of 0 but limits of agreement of ±0.15, which is still wide for clinical 
application.
The same pattern was observed for T1 mapping (n = 30). The R2 was 0.94 for MSI > 0.50 and was 0.43 for 
MSI < 0.50 (3 out of 30 patients resulted in a negative MSI using the 3-slice strategy).
MSI: 3-slice (3 slices for both MI size and AAR) versus full LV coverage, n = 48. When MSI was 
calculated using 3 slices for both MI size and T2 AAR, there was no significant difference between MSIfull LV and 
the MSI3-slices (P = 0.11) as shown in the box and whisker plots in Fig. 3. There was a moderate correlation between 
the two (R2 0.79) and Bland-Altman analysis showed a small bias of 0.03 but a wide limit of agreement of ±0.24. 
Of note, none of the MSI obtained were negative. Visually, there was a wider dispersion between the points and 
the correlation line for those with MSI < 0.50 than those with MSI > 0.50 in Fig. 5a, which was also reflected in 
the Bland-Altman plot (Fig. 5b). The R2 was 0.28 for those with MSI < 0.50 and 0.65 for those with MSI > 0.50.
Discussion
These results suggest that although a 3-slice approach had a good correlation with the full LV approach both 
for the edema-based AAR and MI size, the limits of agreements were quite wide for clinical application and the 
Figure 1. Performance of the full LV coverage versus 3-slice approach for the T2-based AAR. (a) The 
correlation between the 2 approaches; (b) The Bland-Altman plot.
Figure 2. Performance of the full LV coverage versus 3-slice approach for the MI size. (a) The correlation 
between the 2 approaches; (b) The Bland-Altman plot.
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derived MSI was inadequate, especially when the MSI was <0.50. Furthermore, when MSI was calculated using 
whole LV coverage for MI size and the 3 slices for AAR as previously done by Hamshere et al.12, this approach 
underestimated the AAR in 7/48 patients for T2 mapping and 3/30 patients for T1 mapping and resulted in a 
negative MSI, which is not plausible in practice and would impact on mean MSI in a cardioprotection study. In 
the clinical setting, it is difficult to know whether a patient would have MSI more than or less than 0.50 prior to 
acquiring the images and the analysis the MI size and AAR data and therefore full LV acquisition of T1 or T2 
maps is recommended when the edema-based AAR needs to be assessed.
Performing a comprehensive CMR study for research purposes to obtain information on MI size, edema-based 
AAR, MVO and extracellular volume fraction in a patient with a recent STEMI can take up to 1 hour and there-
fore shortening the CMR duration is highly desirable. Recently, a 3-slice approach for assessing the AAR by 
T2-weighted STIR imaging has been shown to perform as well as full LV coverage and offered the possibility to 
shorten the scan time12. However, T2-weighted imaging has several limitations including the subjective inter-
pretation of the images, variations in regional myocardial intensity due to changes in sensitivity of surface coils, 
blood-pooling artefacts at the subendocardial border, its relatively low contrast-to-noise ratio between normal 
and abnormal myocardium, and its susceptibility to breathing and motion artefacts13, 14. T1 and T2 mapping has 
recently emerged as a more robust technique to delineate the edema-based AAR11 and both these techniques at 
1.5 T correlated well with the AAR by single photon emission tomography15 and performed equally well against 
each other in the clinical setting5. However, unlike in the study by Hamshere et al.12, the 3-slice approach did not 
perform well against full LV approach using T1 and T2 mapping, especially in those patients with MSI < 0.50. 
Figure 3. Performance of the 3 approaches for the T2-based MSI. Box and whisker plots of the MSI by T2 
using full LV coverage for both the MI size and AAR; 3-slice approach for AAR and full LV coverage for the MI 
size; and 3-slice approach for both the MI size and AAR. The MSI using 3-slice approach for AAR and full LV 
coverage for the MI size resulted in negative MSI in 7 patients.
Figure 4. Correlation between the MSI derived by the 2 approaches, subdivided by MSI above or below 0.50. 
The dotted lines represent the line of identity. The dashed lines represent the lines passing through 0 on the x 
and y-axis.
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Although they included a larger number of patients, the mean MI size and AAR was much smaller in their cohort 
(MI size: 18% LV versus 27% LV; AAR: 27% LV versus 41% LV) and MSI was larger (41% versus 35%) when com-
pared to our cohort.
Limitations. Our sample size for comparing 3-slice versus full LV coverage was 48 compared to 85 in the 
previous study12 and no formal power calculation was performed prospectively. However, we used the more 
robust edema-based AAR technique (both T1 and T2 mapping) and included patients with a range of MI size 
and AAR. A retrospective power calculation (PASS 15 Power Analysis and Sample Size Software (2017). NCSS, 
LLC. Kaysville, Utah, USA, ncss.com/software/pass) for paired measurements from a sample size of 48 achieved 
100% power to detect non-inferiority using a one-sided t-test when the margin of non-inferiority was set at 0.00% 
and the true difference between the mean (1.70%) and the standard deviation (6.45%) were derived from the 
Bland-Altman analysis (significance level (alpha) of 0.15). We did not have T2-weighted STIR images acquired 
for these patients for comparison.
Conclusion
Despite the clear benefits of a shorter scan and analysis time, we caution against using a 3-slice approach for the 
edema-based AAR by T1 and T2 mapping, especially in those with MSI < 0.50. Full LV coverage should remain 
the quantification approach of choice for the AAR in clinical cardioprotection studies.
Methods
Study Population. 48 acute STEMI patients reperfused by PPCI from a recently reported cohort were 
included in this study16–20. In brief, the London-Harrow Research Ethics Committee approved this study. These 
patients were prospectively recruited between August 2013 and July 2014 following informed consent. All 
research-related procedures were performed in accordance with the local guidelines and regulations. The man-
agement of STEMI was as per current guidelines21. Study exclusion criteria were known previous MI and standard 
recognized contraindications to CMR.
Imaging acquisition. All CMR scans were performed on a 1.5 Tesla scanner (Magnetom Avanto, Siemens 
Medical Solutions) using a 32-channel phased-array cardiac coil. Full LV coverage native T1 mapping was avail-
able in 30 patients. Full LV coverage for T2 mapping and late gadolinium enhancement (LGE) were available in 
all 48 patients.
Native T1 mapping (Work in Progress #448B). Native T1 maps were acquired with a steady state free precession 
(SSFP)-based modified Look-Locker inversion recovery (MOLLI) sequence (flip angle = 35°; pixel bandwidth 
977 Hz/pixel; voxel size = 1.5 × 1.5 × 6.0 mm; echo time = 1.1 ms; matrix = 256 × 144; slice thickness = 6 mm with 
4 mm gap) using a 5s(3s)3s modified sampling protocol22. Motion correction and a non-linear least-square curve 
fitting of the set of images acquired at different inversion times were performed inline by the scanner to generate 
a pixel-wise colored T1 map23.
T2 mapping (Work in Progress #448B). Colored T2 maps consisting of pixel-wise T2 values (Work In 
Progress 448B, Siemens Healthcare) were generated following motion correction and fitting to estimate T2 
relaxation times9 after acquiring 3 single-shot images (flip angle = 70°; pixel bandwidth 930 Hz/pixel; voxel 
size = 2.0 × 2.0 × 6.0 mm; echo time = 1.1 ms; repetition time = 3 × R-R interval; matrix = 116 × 192; slice thick-
ness = 6 mm with 4 mm gap) at different T2 preparation times (0 ms, 24 ms, and 55 ms, respectively).
Figure 5. Performance of the full LV coverage versus 3-slice approach (both for the AAR and the MI size) for 
the MSI. (a) The correlation between the 2 approaches; (b) The Bland-Altman plot.
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LGE imaging. LGE imaging was acquired with a standard segmented ‘fast low-angle shot’ two-dimensional 
inversion-recovery gradient echo sequence or a respiratory motion-corrected, free-breathing single shot SSFP 
averaged phase sensitive inversion recovery sequence24, 25 at 10–15 minutes after the injection of 0.1 mmol/kg of 
Gadoterate meglumine (Gd-DOTA marketed as Dotarem, Guerbet S.A., Paris, France).
Imaging analysis. All imaging analysis was performed using CVI42 software (Version 5.1.2[303], Calgary, 
Canada). The imaging analysis methods have been previously described16–18. In brief, the endocardial and epi-
cardial borders were manually drawn on the LGE, T1 and T2 maps. Areas of hypo-intense core of microvascular 
obstruction were included as part of the MI zone and AAR.
For the full LV coverage approach, MI size was quantified using a signal intensity threshold of 5 standard 
deviations (SD) above the normal remote myocardium4 and expressed as a percentage of the whole LV (% LV). All 
the short axis LGE images covering the whole LV were used to quantify MI size. The full LV edema-based AAR 
(AARfull LV) from the T1 and T2 maps were quantified using a threshold of 2-SD above the remote myocardium 
and expressed as % LV.
For the 3-slice approach, only basal, mid and apical LV slices for MI size and AAR were analyzed using the 
same approach by Hamshere et al.12 and as illustrated in Fig. 6. In brief, the basal LV slice was chosen as the first 
short axis slice basally below the LV short axis with left ventricular outflow track. The mid LV slice was the short 
axis slice with papillary muscle heads visible and at distance of at least 2 slices from the basal LV slice. The apical 
LV slice was the short axis slice at a distance of at least 2 slices from the mid LV slice and with visible LV cavity 
present on the short axis. T1, T2 maps and LGE images with matching slice position were used for the AAR3-slices 
and MI size3-slices quantification.
Statistical analysis. SPSS version 22 (IBM Corporation, Illinois, US) was used for all statistical analysis. 
Shapiro-Wilk Test was used to assess for normality. Continuous data was expressed as mean ± standard deviation 
(SD) or median (interquartile range) and categorical data was reported as frequencies and percentages. Groups 
were compared using paired Student t-test/Wilcoxon signed rank test or unpaired Student t-test/Mann Whitney 
U test where appropriate. Correlation was assessed using either Pearson’s correlation coefficient for normally 
distributed data or Spearman’s rho for non-normally distributed data. Bland-Altman analysis was performed 
for inter-method agreement and expressed as bias and limits of agreement (±2 SD). All statistical tests were 
two-tailed, and P < 0.05 was considered statistically significant.
Figure 6. Matching T2 maps, T1 maps and LGE images of a patient with an inferior STEMI. This figure shows 
the selection of 3 slices (basal, mid and apical) of T2 maps, T1 maps and LGE images from the full LV coverage 
images of a patient with an inferior STEMI, and with the 3-chamber view as reference.
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